EN
Patient-first cell therapy innovation
 
2021
  • 0
Huang D., Wang Y., Thompson J.W., Yin T., Alexander P.B., Qin D., Mudgal P., Wu H., Liang Y., Tan L., Pan C., Yuan L., Wan Y., Li Q.-J.,* and Wang X.F. (2021) Cancer Cell-Derived GABA Promotes β-Catenin-Mediated Tumor Growth and Immunosuppression. Nature Cell Biology (Accepted *: Corresponding authors)

Ha N., Ding N., Hong R., Liu R., Roca X., Luo Y., Duan X., Wang X., Ni P., Wu H., Zhang L.F.*, Chen L*. (2021) The lupus autoantigen La/Ssb is an Xist-binding protein involved in Xist folding and cloud formation. Nucleic Acids Res. (20):11596-11613. (*: Corresponding authors, PMCID: PMC8599922)

Zheng Z., Qiu X., Wu H., Chang L., Tang X., Zou L., Li J., Wu Y., Zhou J., Jiang S., Wan Y., Ni Q. (2021) TIPS: trajectory inference of pathway significance through pseudotime comparison for functional assessment of single-cell RNAseq data. Brief Bioinform. 22(5):bbab124. (*: Corresponding authors, PMCID: PMC8425418)

Wang G., Mudgal P., Wang L., Shuen T.W.H., Wu H., Alexander P.B., Wang W.W., Wan Y., Toh H.C.*, Wang X.-F.*, and Li Q.-J.* (2021) TCR repertoire characteristics predict clinical response to adoptive CTL therapy against nasopharyngeal carcinoma. Oncoimmunology. 10(1):1955545. (*: Corresponding authors, PMCID: PMC8331028)

Christian L.S., Wang L., Wu H., Deng D., Lim B., Wang X.-F. and Li Q.-J. (2021) Resident Memory T Cells in Tumor-Distant Tissues Fortify Against Metastasis Formation. Cell Reports 35(6)109118 (PMCID: PMC8204287)

Jia Q., Qin D., He F., Xie Q., Ying Z., Zhang Y., Song Y., Cheng J.N., Zuo X., Xu L., Fang H., Hu C., Peng L., Jin T., Shi Z., Alexander P.B., Wang Y., Liu Y., Han W., Zhu J., Wang P.*, Li Q.-J.*, Zhu B.* (2021) Peripheral eosinophil counts predict efficacy of anti-CD19 CAR-T cell therapy against B-lineage non-Hodgkin lymphoma. Theranostics 11(10):4699-4709. (*: Corresponding authors, PMCID: PMC7978305)

Cheng J.-N., Luo W., Sun C., Jin Z., Zeng X., Alexander P.B., Gong Z., Xia X., Ding X., Xu S., Zou P., Wan Y., Jia Q. *, Li Q.-J.*, & Zhu B. (2021) Radiation-Induced Eosinophils Improve Cytotoxic T Lymphocyte Recruitment and Response to Immunotherapy. Sci. Adv. 7(5):eabc7609. (*: Corresponding authors, PMCID: PMC7846170)

Wang S., Sun F., Huang H., Chen K., Li Q.J., Zhang L., Wang E., Wang C., Zhang H., Yuan A.Q., Chen B., Deng T., Liu Y., Sun J., Liu D., Yu Y., Fang Y., Jiang N., Wu D., Fang H., Bai Y., Xing S., Ni Y., Fan Q., Yu A., Sun C., Tang Y., Li N., Xu B., He J. (2021) The Landscape of Cell and Gene Therapies for Solid Tumors. Cancer Cell. 39(1):7-8. (PMID: 33434513)
03.23
2022
Source:天科雅
Keysword:
Related Reading

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer
About TCRCure
Research and Development
Product and Cinical trial
News and Media
Recruitment

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer